CONTEXT
Wolff-Parkinson-White (WPW) syndrome is a cardiac disorder due to the abnormal presence of an additional electrical conduction pathway, called the accessory pathway, between the atria and the ventricles. This syndrome is a common cause of tachycardia attacks. It can be diagnosed with an electrocardiogram or electrophysiology study by introducing probes into the heart. If in the first case the diagnosis is not always effective,* in the second one it consists of an invasive examination for the patient. The main treatment of WPW syndrome is the elimination of the accessory pathway by radiofrequency catheter ablation.
DESCRIPTION
Recently, researchers at the Le2i laboratory have developed an automated algorithm to accurately identify the presence of the accessory pathway for an accurate and effective diagnosis of WPW syndrome. The interest of the approach is to locate precisely the accessory pathway in an automated way from a standard 12-lead electrocardiogram (ECG). This application will assist in performing the probe-based invasive endocavitary electrophysiology and ablation procedure. The prototype software has been validated on a first group of 76 patients with the syndrome (all genders and ages), and an additional validation test is currently underway on a larger group of patients (385).
COMPETITIVE ADVANTAGES
MARKET & APPLICATIONS
Medicine - cardiac diagnosis :
DEVELOPMENT STAGE
Prototype validated on a group of 76 patients with WPW syndrome
RESEARCH TEAM
Laboratory "Electronique, Informatique et Image" (Le2i) CNRS - University of Burgundy
INTELLECTUAL PROPERTY
Software registered at the APP the February 6th, 2018
TARGET PARTNERSHIP
Software licensing
CONTACT
Ludmila MONTEIRO
Business Development Manager
+33 (0)6 31 10 21 21
ludmila.monteiro@sattge.fr